- About Us
- Our Taskforces
Awareness Raising Taskforce
Taskforce mandate: To increase awareness of head and neck cancer among the general public and the media.
The Awareness Raising taskforce aims to raise awareness of head and neck cancer among the general public and the media. It does this through a detailed programme of activities that aim to encourage a healthy lifestyle, earlier presentation, diagnosis and referral to healthcare professionals, which culminates in an annual pan-European Awareness Week that is held in September.
Healthcare Professional (HCP) Education Taskforce
Taskforce mandate: To raise awareness of the signs and symptoms of head and neck cancer among general practitioners (GPs) and to encourage improved patient care.
The HCP Education taskforce aims to develop educational tools to reach primary care physicians, professional groups and other referring clinicians. These tools will aid the earlier presentation, diagnosis and referral of patients with head and neck cancer, and ultimately achieve a universal understanding of the signs and symptoms healthcare professionals should look for when diagnosing head and neck cancer.
Partnership Building Taskforce
Taskforce mandate: To expand relationships with European and national-level members of parliament, as well as supporting the exchange of knowledge across patient groups.
The Partnership Building taskforce aims to work closely with European members of parliament to increase head and neck cancer on the European health agenda and to support groups for the exchange of knowledge among each other and other relevant European stakeholders. This will facilitate the ultimate aim of encouraging earlier presentation, diagnosis and referral of patients with head and neck cancer.
Emotive Support Taskforce
Taskforce mandate: To raise awareness of the importance of psychological support tools for patients with head and neck cancer.
The Emotive Support taskforce aims to review current data/clinical practice to better understand the emotive support that is available to patients with head and neck cancer. The group will develop recommendations for important improvements that need to be made at a European level to support the patient journey.